Editas Medicine EDIT
NASDAQ EDIT
$2.46 -0.05 (-1.99%)
As of: Oct 22, 2026 · 3:41 PM EDT

Editas Medicine (EDIT) Other financing activities (2018)

Updated

Editas Medicine (EDIT) reported Other financing activities of $80,000 for FY2015.

Analysis

Editas Medicine (EDIT) Other financing activities (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.46 Bn 1,139.04 Bn 19.71 Bn
2 Johnson & Johnson 648.38 Bn 568.24 Bn 17.30 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn
4 Merck 367.73 Bn 322.11 Bn 12.21 Bn
5 Novartis Ag 303.35 Bn 267.34 Bn 11.24 Bn
6 Astrazeneca 268.20 Bn 241.88 Bn 12.86 Bn
7 Amgen 242.55 Bn 197.95 Bn 7.24 Bn
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn
10 Editas Medicine 221.62 Mn -490.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 -100,000.00
API Access

Editas Medicine Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=EDIT&period=max&api_key=YOUR_API_KEY